Genetic knockout of SIRT2 and small molecule SIRT2 inhibitors both show neuroprotection against the neurotoxicity observed in a Parkinson’s disease cell model and a transgenic mouse model [12,21,22]. This evidence concerns the gene SIRT2 and Parkinson disease.